Profile
Francesco Parlati was the founder of Cleave Therapeutics, Inc. (founded in 2010) where he held the title of Senior Director-Biology from 2010 to 2012.
He also worked at Proteolix, Inc. as an Associate Director-Biology from 2004 to 2009.
Prior to that, he was a Scientist at Rigel Pharmaceuticals, Inc. from 2001 to 2003.
Currently, Dr. Parlati is the Senior Vice President-Research at Calithera Biosciences, Inc. (2012-present).
Dr. Parlati obtained his doctorate degree from McGill University in 1996 and completed his undergraduate studies at Concordia University.
Former positions of Francesco Parlati
| Companies | Position | End |
|---|---|---|
| CALITHERA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Founder | 2011-12-31 |
Proteolix, Inc.
 Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Corporate Officer/Principal | 2009-09-30 |
| RIGEL PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2003-11-30 |
Training of Francesco Parlati
| McGill University | Doctorate Degree |
| Concordia University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Proteolix, Inc.
Proteolix, Inc. Pharmaceuticals: MajorHealth Technology Proteolix, Inc. manufactures bio-pharmaceutical related products. It engages in the discovery, development, and marketing of pharmaceutical products to treat cancer and immunological conditions. The company was founded by Susan M. Molineauxf in December 2003 and is headquartered in South San Francisco, CA | Health Technology |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Francesco Parlati
